Why Integrating Biology May Become More Valuable Than Sequencing It
Curator’s Note: The article highlights a significant transition in the understanding of biology, moving from mere genomic sequencing to the integration of diverse biological data. While sequencing has transformed biomedical research, the focus is now on how to turn this data into comprehensive biological knowledge. The author discusses Illumina Connected Multiomics as a pivotal platform that exemplifies this shift towards biological intelligence, merging various molecular datasets to reveal critical relationships. This integrated approach is crucial for future precision medicine, drug discovery, and personalized therapies, suggesting that the true value of technological advances in biology lies not in data accumulation but in improving scientific understanding.
Author’s Note: This article reflects my perspectives as a cognitive scientist, enterprise architect, healthcare technologist, and author of Technology Horizons 2050 and Beyond. It is intended for educational purposes and should not be interpreted as medical, investment, or purchasing advice.
1. We May Be Witnessing Another Architectural Transition
When new technologies emerge, public attention usually focuses on the visible innovation. During the early days of cloud computing, discussions centered on virtual machines and remote storage. Artificial intelligence initially captured attention through chatbots, image generation, and autonomous systems. Only later did business leaders recognize that the deeper transformation concerned infrastructure rather than individual applications.
I believe biology is beginning to experience a remarkably similar transition. Over the past two decades, genomic sequencing has revolutionized biomedical research and clinical science. Sequencing technologies enabled researchers to read DNA with unprecedented speed, scale, and affordability. Yet as remarkable as this progress has been, sequencing alone has never been the destination. It has been the starting point.
The more important question has gradually become how to transform biological data into biological understanding. That question immediately attracted my attention when I began examining Illumina Connected Multiomics. Although often described as another cloud-based bioinformatics platform, I believe it represents something considerably more significant. From an enterprise architecture perspective, it may signal the early emergence of what I describe as biological intelligence platforms, environments designed not merely to generate biological information but to integrate, interpret, and continuously expand biological knowledge.
2. Biology Was Not Meant to Be Read One Layer at a Time
One of the fascinating characteristics of human biology is that it functions as an integrated system rather than a collection of independent components.
Genes provide the biological blueprint. Epigenetic mechanisms influence how those genes are regulated. RNA reflects which genes are actively expressed. Proteins perform the work of the cell. Metabolites reveal the biochemical consequences of countless cellular processes. The microbiome continuously interacts with immunity, metabolism, and neurological function. Environmental exposures, nutrition, sleep, physical activity, and aging influence every one of these layers.
Physicians have long understood that human health cannot be explained by a single laboratory value. Similarly, researchers increasingly recognize that one molecular layer rarely provides a complete biological picture. This is precisely where multiomics becomes important.
Rather than analyzing genomics, transcriptomics, proteomics, and other molecular datasets independently, platforms such as Illumina Connected Multiomics seek to correlate these diverse sources of biological information within a unified cloud environment. The objective is not simply to display more data. It is to reveal biological relationships that remain difficult to identify when each dataset is examined in isolation.
From my perspective, this represents an architectural shift from biological data management toward biological knowledge integration.
3. From Sequencing Platforms to Biological Intelligence Platforms
While studying NVIDIA’s evolution, I observed that the company gradually shifted from selling graphics processors to building computational infrastructure for the intelligence economy. Illumina appears to be following an analogous, although distinctly healthcare-oriented, trajectory.
Its sequencing instruments remain foundational technologies. Increasingly, however, the company’s broader contribution appears to involve enabling researchers to transform biological information into actionable knowledge through cloud computing, artificial intelligence, advanced visualization, and collaborative scientific workflows.
That distinction is profound. Organizations do not generate medical breakthroughs simply because they possess more biological data. Breakthroughs occur when diverse forms of biological intelligence can be connected, interpreted, validated, and translated into better scientific understanding.
Platforms capable of supporting that integration may ultimately become as strategically important as the sequencing technologies that generated the information in the first place.
From my perspective, genomic sequencing belongs within this historical progression. Many people understandably associate DNA sequencing with genetics laboratories or highly specialized research institutions. Yet its implications extend far beyond molecular biology. Sequencing technologies provide a means of reading one of the most fundamental information systems in nature, including epigenomics. Rather than focusing solely on the visible manifestations of disease, researchers can investigate the biological instructions that influence health, development, aging, and susceptibility to illness throughout life.
This capability changes the nature of medical inquiry. Scientists no longer ask only what disease looks like after symptoms appear. They can investigate why biological systems behave differently between individuals, why certain therapies succeed or fail, why cancers evolve, why rare diseases develop, and why some people remain remarkably healthy despite environmental and genetic risks.
4. Why This Matters Beyond Research Laboratories
Many readers may assume that platforms such as Connected Multiomics are relevant only to genomic scientists or biotechnology companies. I believe the implications extend much further.
Future precision medicine will increasingly depend upon integrating multiple forms of biological information into coherent clinical knowledge. Drug discovery will require sophisticated computational models capable of identifying subtle molecular interactions.
Cancer care will continue moving toward highly personalized therapeutic strategies. Rare diseases may become diagnosable earlier through integrated biological analysis. Healthy longevity research may increasingly rely upon continuous interpretation of molecular changes occurring throughout life.
Artificial intelligence undoubtedly contributes to each of these developments. Yet artificial intelligence cannot generate meaningful healthcare insights without trustworthy biological information organized within coherent computational environments.
In this sense, biological intelligence platforms become foundational infrastructure supporting future medicine rather than simply another category of healthcare software.
5. Reading Between the Lines In Technology Revolution Progress
While reflecting on Illumina Connected Multiomics, I found myself returning to a broader idea that has gradually emerged throughout my recent work. Technological revolutions are not remembered for individual products. History remembers the infrastructures they create.
Railways transformed industrial economies. Electrical grids transformed manufacturing. The internet transformed communication. Cloud computing transformed enterprise technology. NVIDIA helped accelerate the computational infrastructure supporting artificial intelligence.
Platforms integrating multiomics may represent a comparable transition for medicine. Rather than asking how we can sequence more genomes, they encourage a different question. How can we integrate biology so effectively that it continuously improves scientific understanding?
That question resonates strongly with the concept of Biological Capital™, which I recently introduced as a strategic framework describing how biological knowledge, computational capability, clinical expertise, collaborative ecosystems, and continuous learning collectively create long-term value for healthcare and society.
Viewed through that lens, Illumina Connected Multiomics is more than a software platform. It illustrates how Biological Capital™ may continue to expand.
Conclusions and Key Takeaways
Whether Illumina Connected Multiomics ultimately becomes the dominant biological intelligence platform remains uncertain. Competition will undoubtedly intensify. Scientific methods will continue evolving. Artificial intelligence will mature. New technologies will emerge, and today’s platforms will inevitably be refined or replaced.
Scientific humility reminds us that innovation rarely follows a perfectly predictable path. Nevertheless, I believe the broader architectural direction is becoming increasingly clear.
The future of medicine will depend less on generating isolated biological datasets and more on integrating diverse biological intelligence into trusted knowledge that can improve research, diagnosis, prevention, and personalized care.
From my perspective, that may prove to be the platform’s most enduring contribution. Its greatest value may not lie in helping researchers analyze more biological information. It may lie in helping humanity understand biology more deeply than ever before.
Reference: Why Illumina May Teach Us More About the Architecture of Future Medicine Than About Today’s Stock Price: Part II: How Should Long-Term Investors Evaluate Companies Building the Infrastructure of Future Medicine and Holistic Healthcare? Case Studies for the Future of the Healthcare Industry by Dr Mehmet Yildiz.
If you missed the previous story of this series, here is the link for easy access:
I Can’t Tell You to Buy NVIDIA Shares Now, But I Can Guide You on How to Evaluate Tech Stocks
Why and How Should Long-Term Investors Evaluate the Companies Building the Infrastructure of Entirely New Economies for…medium.com
Thank you for reading my perspectives. I wish you a healthy and happy life.
[End of the Chapter]
Updates on My Creative Work with Relevant Links
I am pleased that my new health and wellness books, What the Brain Needs, Why We Fail, and How We Can Fix It, Ketosis + BDNF: The Healing Molecules That Saved My Life, Cellular Intelligence, Feel Better, Live Smarter, Thrive Anywhere, How I Accelerated My Learning Effortlessly for a Happier Life, Healthspan Mastery, The Science & Wisdom of Graceful Aging, and the Subconsious book, were published and are now available in many bookstores, as part of my Health, Wellness, and Cognitive Performance Series.
You can check out my FEATURED series of 60+ books on Amazon markets:
Some of my books are published at Apple Stores, Smashwords, Vivlio, Kobo, Barnes & Noble, BooksaMillion, Fable, Bookshop.org, or my discount bookstore.
If you are a writer, you are welcome to join my publications by sending a request via this link. I support 43K writers who contribute to my publications on this platform. Check out the recent update for the writers of my publications.
You can contact me via my website. If you are a new writer, check out my writing list to find some helpful stories for your education. You can also join my author platform as a guest blogger.
I interviewed several new professionals and thought leaders. You can find them linked at the end of the latest one.
I invite you to subscribe to my publications on Substack, where I offer experience-based and original content on health, content strategy, book authoring, and technology topics you can’t find online to inform and inspire my readers.
Healthspan Mastery (NEW)
Get an email whenever Dr. Mehmet Yildiz publishes. He is a top writer and editor on Medium.
dr-mehmet-yildiz.medium.com
Check out Free Blog Posts by Digitalmehmet Contributors. Here is the link to my FREE personal blogs. Now you can read our blog posts via a Flipboard Magazine for convenience.
I invite you to explore some of my books on my discount bookstore including: Train Your Brain for a Healthier and Happier Life, Cortisol Clarity, Substack Mastery Version 2, The Zen of Book Authoring, Monetize Your Passion with WooCommerce, Agile Business Architecture for Digital Transformation V2, Agile Business Architecture for Digital Transformation (Audiobook), A Powerful Toolkit for Substack Newsletter Mastery, Smart and Ethical SEO, Modern Affiliate Marketing for Writers, 4 Pillars of Enterprise Architecture, and Smart Email Marketing Content Integration, The Mysterious Leadership Mind of Robert F. Kennedy Jr.,
Why I Wrote the Second Volume of the NVIDIA Book — The Digitalmehmet Content Ecosystem
Leave a Reply